Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma.

Fennell DA, C Steele JP, Shamash J, Sheaff MT, Evans MT, Goonewardene TI, Nystrom ML, Gower NH, Rudd RM.

Lung Cancer. 2005 Feb;47(2):277-81.

PMID:
15639727
[PubMed - indexed for MEDLINE]
2.

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.

Zucali PA, Ceresoli GL, Garassino I, De Vincenzo F, Cavina R, Campagnoli E, Cappuzzo F, Salamina S, Soto Parra HJ, Santoro A.

Cancer. 2008 Apr 1;112(7):1555-61. doi: 10.1002/cncr.23337.

PMID:
18286536
[PubMed - indexed for MEDLINE]
Free Article
3.

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma.

Stebbing J, Powles T, McPherson K, Shamash J, Wells P, Sheaff MT, Slater S, Rudd RM, Fennell D, Steele JP.

Lung Cancer. 2009 Jan;63(1):94-7. doi: 10.1016/j.lungcan.2008.04.001. Epub 2008 May 16.

PMID:
18486273
[PubMed - indexed for MEDLINE]
4.

A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.

Kovac V, Zwitter M, Rajer M, Marin A, Debeljak A, Smrdel U, Vrankar M.

Anticancer Drugs. 2012 Feb;23(2):230-8. doi: 10.1097/CAD.0b013e32834d7a1c.

PMID:
22027538
[PubMed - indexed for MEDLINE]
5.

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.

Fizazi K, Doubre H, Le Chevalier T, Riviere A, Viala J, Daniel C, Robert L, Barthélemy P, Fandi A, Ruffié P.

J Clin Oncol. 2003 Jan 15;21(2):349-54.

PMID:
12525529
[PubMed - indexed for MEDLINE]
Free Article
6.

Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients.

Porta C, Zimatore M, Bonomi L, Imarisio I, Paglino C, Sartore-Bianchi A, Mutti L.

Lung Cancer. 2005 Jun;48(3):429-34. Epub 2005 Jan 24.

PMID:
15893013
[PubMed - indexed for MEDLINE]
7.

Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.

Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.

Lung Cancer. 2005 Apr;48(1):129-35. Epub 2004 Dec 21.

PMID:
15777980
[PubMed - indexed for MEDLINE]
8.

Phase II study of vinorelbine in patients with malignant pleural mesothelioma.

Steele JP, Shamash J, Evans MT, Gower NH, Tischkowitz MD, Rudd RM.

J Clin Oncol. 2000 Dec 1;18(23):3912-7.

PMID:
11099320
[PubMed - indexed for MEDLINE]
Free Article
9.

Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).

Pinto C, Marino A, De Pangher Manzini V, Benedetti G, Galetta D, Mazzanti P, Del Conte G, dell'Amore D, Piana E, Giaquinta S, Lopez M, Martoni A.

Lung Cancer. 2006 May;52(2):199-206. Epub 2006 Mar 20.

PMID:
16542747
[PubMed - indexed for MEDLINE]
10.

Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.

Guadagni S, Clementi M, Valenti M, Fiorentini G, Cantore M, Kanavos E, Amicucci G.

In Vivo. 2006 Nov-Dec;20(6A):715-8.

PMID:
17203752
[PubMed - indexed for MEDLINE]
Free Article
11.

Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer: final results of a multicenter phase II study.

Monnet I, de CH, Soulié P, Saltiel-Voisin S, Bekradda M, Saltiel JC, Brain E, Rixe O, Yataghene Y, Misset JL, Cvitkovic E.

Ann Oncol. 2002 Jan;13(1):103-7.

PMID:
11863089
[PubMed - indexed for MEDLINE]
Free Article
12.

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.

Sørensen JB, Frank H, Palshof T.

Br J Cancer. 2008 Jul 8;99(1):44-50. doi: 10.1038/sj.bjc.6604421. Epub 2008 Jun 10.

PMID:
18542078
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials.

Fennell DA, Parmar A, Shamash J, Evans MT, Sheaff MT, Sylvester R, Dhaliwal K, Gower N, Steele J, Rudd R.

J Clin Oncol. 2005 Jan 1;23(1):184-9.

PMID:
15625372
[PubMed - indexed for MEDLINE]
Free Article
14.

A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma.

Zimling ZG, Sørensen JB, Gerds TA, Bech C, Andersen CB, Santoni-Rugiu E.

Cancer Chemother Pharmacol. 2012 Nov;70(5):743-54. doi: 10.1007/s00280-012-1965-0. Epub 2012 Sep 8.

PMID:
22960937
[PubMed - indexed for MEDLINE]
15.

Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).

Parra HS, Tixi L, Latteri F, Bretti S, Alloisio M, Gravina A, Lionetto R, Bruzzi P, Dani C, Rosso R, Cosso M, Balzarini L, Santoro A, Ardizzoni A.

Cancer. 2001 Aug 1;92(3):650-6.

PMID:
11505411
[PubMed - indexed for MEDLINE]
16.

Oxaliplatin and raltitrexed in the treatment of inoperable malignant pleural mesothelioma: results of a pilot study.

Maisano R, Caristi N, Toscano G, Aragona M, Spadaro P, Amadio P, Mare M, Zavettieri M, La Torre F.

Tumori. 2001 Nov-Dec;87(6):391-3.

PMID:
11989592
[PubMed - indexed for MEDLINE]
17.

Phase II study of vinflunine in malignant pleural mesothelioma.

Talbot DC, Margery J, Dabouis G, Dark G, Taylor H, Boussemart H, Cadic V, Pinel MC, Rivière A, Ollivier L, Ruffié P.

J Clin Oncol. 2007 Oct 20;25(30):4751-6.

PMID:
17947722
[PubMed - indexed for MEDLINE]
Free Article
18.

Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.

Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.

J Thorac Oncol. 2008 Sep;3(9):994-1002. doi: 10.1097/JTO.0b013e31818396cb.

PMID:
18758302
[PubMed - indexed for MEDLINE]
19.

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

Castagneto B, Zai S, Dongiovanni D, Muzio A, Bretti S, Numico G, Botta M, Sinaccio G.

Am J Clin Oncol. 2005 Jun;28(3):223-6. Erratum in: Am J Clin Oncol. 2005 Oct;28(5):444. Sinaccio, G [added].

PMID:
15923792
[PubMed - indexed for MEDLINE]
20.

Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study.

Katirtzoglou N, Gkiozos I, Makrilia N, Tsaroucha E, Rapti A, Stratakos G, Fountzilas G, Syrigos KN.

Clin Lung Cancer. 2010 Jan;11(1):30-5. doi: 10.3816/CLC.2010.n.005.

PMID:
20085865
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk